Annual Conference

Now Open! Call for Abstracts for the General Poster Session

NCCN welcomes original abstracts from investigators in the general oncology community. Submissions will be accepted from academic institutions, teaching and community hospitals, or industry. Participants from both NCCN and non-NCCN Member Institutions may submit abstracts.

The NCCN General Poster Session, including submission review, is overseen by the NCCN Oncology Research Program (ORP). The submission deadline is Wednesday, November 9, 2022, 11:59 pm ET. Corresponding authors can expect to receive notification via e-mail in mid-December 2022. For more details on the abstract submission process and poster specifications, please see the Poster Session FAQs.

Submit Abstract

Save the dates!

NCCN 2023 Annual Conference
Orlando World Center Marriott • Orlando, FL
Friday, March 31, 2023 – Sunday, April 2, 2023

NCCN 2023 Nursing Program: Advancing Oncology Nursing™
Orlando World Center Marriott • Orlando, FL
Thursday, March 30, 2023

NCCN 2024 Annual Conference
Orlando World Center Marriott • Orlando, FL
Friday, April 5, 2024 – Sunday, April 7, 2024

2022 Recorded Continuing Education Sessions

More than 30 recorded educational sessions from the NCCN 2022 Annual Conference are now available!

View topics below or visit education.nccn.org/ac2022 for more information.

Plenary Sessions

Best Practices in Oncology

Ampullary Adenocarcinoma

Principles of Management of Patients with Ampullary Adenocarcinoma

Anal Cancer

New Approaches for the Treatment of Patients with Anal Carcinoma

Bladder Cancer

New Treatment Options for Patients with Bladder Cancer

Breast Cancer

Colorectal Cancer

Head and Neck Cancers

Treatment De-Intensification for Patients with HPV-Positive Head and Neck Cancers

Hematologic Malignancies

Hepatocellular Carcinoma

Liver-Directed and Systemic Therapy Options for Hepatocellular Carcinoma

Medical Generics and Genomics

Best Practices for Genetic Risk Assessment and Counseling

Non-Small Cell Lung Cancer

Oncology Research

Updates in Oncology: Oral Presentations from the NCCN Poster Sessions

Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma: Emerging Systemic Therapy Options

Prostate Cancer

Management of Patients with Non-Metastatic Prostate Cancer

Skin Cancers

Supportive Care and Survivorship

2022 Annual Conference Supporters

This activity is supported by educational grants from:

Abbott Molecular
Astellas and Seagen Inc.
AstraZeneca
BeiGene
Coherus BioSciences
Daiichi Sankyo
Eisai
Exact Sciences
Genentech, a member of the Roche Group
Genmab, US Inc.
Gilead Sciences, Inc. and Kite, A Gilead Company
GlaxoSmithKline
GRAIL, LLC
Kadmon Corporation, LLC.
Lantheus Medical Imaging Inc.
Lilly
Menarini-Stemline
Novartis
NOVOCURE
Olympus Corporation of the Americas
Pfizer Inc.
Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Puma Biotechnology
SpringWorks
Taiho Oncology, Inc.

This educational activity is supported by a medical education grant from Karyopharm Therapeutics

This educational activity is supported by an independent medical education grant from Illumina, Inc.

This activity is supported by an independent educational grant from AbbVie, Bristol Myers Squibb, Incyte and Merck & Co., Inc.

This project has been made possible in part by a grant from Varian Medical Systems, a Siemens Healthineers company /Global Medical Education Grant Program

This activity has been supported by an unrestricted educational grant from GE Healthcare, Pharmaceutical Diagnostics

This activity is supported by educational funding provided by Amgen